Loading insider details...
Beta
Latest Form 4 (Sep 14, 2026): Sale of 9,768 AMLX shares, $315.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 9,768 | $315.2K |
| Aug 21, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 22,807 | n/a |
| Mar 9, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 95,990 | n/a |
| Mar 4, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 7,909 | $114.9K |
| Feb 4, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 3,557 | $52.1K |
| Jan 8, 2026 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 3,326 | $37.0K |
| Oct 2, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 10,558 | $154.7K |
| Apr 2, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Sale | 10,896 | $37.8K |
| Mar 11, 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Grant/Award | 68,420 | n/a |
| Sep 16, 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Purchase | 40,000 | $101.4K |